LEPROT and type 2 diabetes mellitus: We detected that individuals with obesity and GI or T2D are characterized by elevated plasma levels of HbA1C and the inflammatory cytokine IL-6, by lower plasma levels of adiponectin (Supplemental Figure 10B), and by higher levels of LEPROT in their adipose tissue (Figure 6B).